Goldan Keith A.
- SEC CIK
- 0001495411
In the past year, 3 open-market sale filings worth $137.0K and no purchases.
Current role at each company
- SNDX Syndax Pharmaceuticals IncChief Financial Officeras of Jun 2, 2026
- ABEO Abeona Therapeutics Inc.Directoras of Apr 7, 2026
- OPTN OptiNose, Inc.Chief Financial Officeras of Mar 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $137.0K
- 3 filings
- Net
- −$137.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Goldan Keith A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SNDX Syndax Pharmaceuticals Inc
Chief Financial Officer8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Goldan Keith A.Chief Financial Officer | SSale | −1.18K | $18.99 | −$22.4K | −0.8%139.3K after | |
| Feb 10, 2026 (view filing) | Feb 9 | 1 day | Goldan Keith A.Chief Financial Officer | SSale | −3.41K | $21.03 | −$71.7K | −2.4%140.4K after | |
| Feb 6, 2026 (view filing) | Feb 6 | Same day | Goldan Keith A.Chief Financial Officer | SSale | −2.08K | $20.62 | −$42.9K | −1.4%143.8K after | |
| Jul 18, 2025 (view filing) | Jul 16 | 2 days | Goldan Keith A.Chief Financial Officer | SSale | −1.30K | $9.29 | −$12.0K | −1.4%92.5K after | |
| May 19, 2025 (view filing) | May 19 | Same day | Goldan Keith A.Chief Financial Officer | PPurchase | +3.00K | – | – | +3.3%93.7K after | |
| Feb 12, 2025 (view filing) | Feb 10 | 2 days | Goldan Keith A.Chief Financial Officer | SSale | −3.78K | $15.50 | −$58.5K | −4.0%90.7K after | |
| Jun 17, 2024 (view filing) | Jun 14 | 3 days | Goldan Keith A.Chief Financial Officer | PPurchase | +1.25K | $20.03 | +$25.0K | +2.4%52.6K after | |
| Jun 14, 2023 (view filing) | Jun 13 | 1 day | Goldan Keith A.Chief Financial Officer | SSale | −577 | $22.31 | −$12.9K | −18.0%2.63K after |
OPTN OptiNose, Inc.
Chief Financial Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2022 (view filing) | Mar 16 | 1 day | Goldan Keith A.Chief Financial Officer | SSale | −4.62K | $2.11 | −$9.74K | −3.2%141.7K after | |
| Dec 17, 2021 (view filing) | Dec 16 | 1 day | Goldan Keith A.Chief Financial Officer | SSale | −580 | $1.64 | −$951.2 | −0.6%89.6K after | |
| Sep 17, 2021 (view filing) | Sep 16 | 1 day | Goldan Keith A.Chief Financial Officer | SSale | −578 | $2.79 | −$1.61K | −0.6%90.2K after |